News Brief: Avalon GloboCare Corp.

News Brief: Avalon GloboCare Corp.

Wednesday, August 30, 2023

Freehold, N.J. based Avalon GloboCare Corp. (NASDAQ: ALBT) today announced that Laboratory Services MSO, LLC (“LSM”) is now offering an in-house laboratory developed test to detect Tuberculosis using a patient’s sputum sample. Avalon owns a 40% interest in LSM.

According to the release, LSM’s new polymerase chain reaction test allows for accurate and rapid identification of Mycobacterium tuberculosis from samples. The use of sputum samples to detect Mtb provides easier collection and transport than blood samples, which are used in protein-based chemiluminescent immuno-assays.

LSM’s PCR-based test can be performed in under 2 hours and the patient needs only one visit to the clinic to provide a sputum sample with no needle stick required.

Avalon GloboCare Corp. is a commercial stage company dedicated to developing and delivering innovative, transformative, precision diagnostics and clinical laboratory services.  

Shares are trading unchanged at 94 cents


Other Penny Stock Movers

News of Secured Permit for Rare Earth Drill Program Moving Shares Higher
News of Silver Discovery Sends Shares Higher
Clinical-Stage Pharma Company Trading Higher on Continued Collaboration for Innovative Overdose Technology
Most Popular
FREE Newsletter


Back to Top